Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tango Therapeutics, Inc. | Director | Common Stock | 11.3K | $81.1K | $7.21 | Jun 5, 2024 | Direct |
HOOKIPA Pharma Inc. | Chief Executive Officer, Director | Common Stock | 109K | $78.8K | $0.73 | Jul 22, 2024 | Direct |
HOOKIPA Pharma Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 49K | Jun 17, 2024 | Direct | ||
Tango Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 37.5K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HOOK | HOOKIPA Pharma Inc. | Jul 22, 2024 | 1 | $0 | 4 | Jul 24, 2024 | Chief Executive Officer, Director |
HOOK | HOOKIPA Pharma Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
TNGX | Tango Therapeutics, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
HOOK | HOOKIPA Pharma Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
TNGX | Tango Therapeutics, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
HOOK | HOOKIPA Pharma Inc. | Jan 1, 2023 | 0 | $0 | 3 | Apr 18, 2023 | Director |
TNGX | Tango Therapeutics, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
TNGX | Tango Therapeutics, Inc. | Aug 10, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Director |